266 related articles for article (PubMed ID: 29890370)
1. Harnessing immune history to combat influenza viruses.
Guthmiller JJ; Wilson PC
Curr Opin Immunol; 2018 Aug; 53():187-195. PubMed ID: 29890370
[TBL] [Abstract][Full Text] [Related]
2. From Original Antigenic Sin to the Universal Influenza Virus Vaccine.
Henry C; Palm AE; Krammer F; Wilson PC
Trends Immunol; 2018 Jan; 39(1):70-79. PubMed ID: 28867526
[TBL] [Abstract][Full Text] [Related]
3. B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat.
Guthmiller JJ; Utset HA; Wilson PC
Viruses; 2021 May; 13(6):. PubMed ID: 34067435
[TBL] [Abstract][Full Text] [Related]
4. Influenza vaccines: 'tailor-made' or 'one fits all'.
Saletti G; Gerlach T; Rimmelzwaan GF
Curr Opin Immunol; 2018 Aug; 53():102-110. PubMed ID: 29734023
[TBL] [Abstract][Full Text] [Related]
5. Immunological responses to influenza vaccination: lessons for improving vaccine efficacy.
Wang TT; Bournazos S; Ravetch JV
Curr Opin Immunol; 2018 Aug; 53():124-129. PubMed ID: 29753885
[TBL] [Abstract][Full Text] [Related]
6. The Multifaceted B Cell Response to Influenza Virus.
Lam JH; Baumgarth N
J Immunol; 2019 Jan; 202(2):351-359. PubMed ID: 30617116
[TBL] [Abstract][Full Text] [Related]
7. Pandemic influenza vaccines: what they have taught us about B cell immunology.
Topham DJ; Nguyen P; Sangster MY
Curr Opin Immunol; 2018 Aug; 53():203-208. PubMed ID: 29957457
[TBL] [Abstract][Full Text] [Related]
8. Mucosal IgA responses in influenza virus infections; thoughts for vaccine design.
van Riet E; Ainai A; Suzuki T; Hasegawa H
Vaccine; 2012 Aug; 30(40):5893-900. PubMed ID: 22835738
[TBL] [Abstract][Full Text] [Related]
9. A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses.
Quiñones-Parra SM; Clemens EB; Wang Z; Croom HA; Kedzierski L; McVernon J; Vijaykrishna D; Kedzierska K
J Virol; 2016 Aug; 90(15):6936-6947. PubMed ID: 27226365
[TBL] [Abstract][Full Text] [Related]
10. Development of an Alternative Modified Live Influenza B Virus Vaccine.
Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
[TBL] [Abstract][Full Text] [Related]
11. Keeping the memory of influenza viruses.
Combadière B; Sibéril S; Duffy D
Pathol Biol (Paris); 2010 Apr; 58(2):e79-86. PubMed ID: 20303671
[TBL] [Abstract][Full Text] [Related]
12. Adaptive B Cell Responses to Influenza Virus Infection in the Lung.
Takahashi Y; Onodera T; Adachi Y; Ato M
Viral Immunol; 2017; 30(6):431-437. PubMed ID: 28661720
[TBL] [Abstract][Full Text] [Related]
13. Memory T Cell Dynamics in the Lung during Influenza Virus Infection.
Pizzolla A; Wakim LM
J Immunol; 2019 Jan; 202(2):374-381. PubMed ID: 30617119
[TBL] [Abstract][Full Text] [Related]
14. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
15. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
Kamlangdee A; Kingstad-Bakke B; Osorio JE
J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
[TBL] [Abstract][Full Text] [Related]
16. High preexisting serological antibody levels correlate with diversification of the influenza vaccine response.
Andrews SF; Kaur K; Pauli NT; Huang M; Huang Y; Wilson PC
J Virol; 2015 Mar; 89(6):3308-17. PubMed ID: 25589639
[TBL] [Abstract][Full Text] [Related]
17. Toward universal influenza virus vaccines: from natural infection to vaccination strategy.
Zhao C; Xu J
Curr Opin Immunol; 2018 Aug; 53():1-6. PubMed ID: 29604600
[TBL] [Abstract][Full Text] [Related]
18. Development of next generation hemagglutinin-based broadly protective influenza virus vaccines.
Nachbagauer R; Palese P
Curr Opin Immunol; 2018 Aug; 53():51-57. PubMed ID: 29680576
[TBL] [Abstract][Full Text] [Related]
19. Immunity to Influenza: Closing in on a Moving Target.
Oltz EM
J Immunol; 2019 Jan; 202(2):325-326. PubMed ID: 30617112
[No Abstract] [Full Text] [Related]
20. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
